S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 92,741 to 92,760 of 146,954

Issue Date	Title / Author(s) / Citation	File
2006	Phase behavior and transition mechanisms of block copolymer solutions and block copolymer nanoparticle mixtures 박문정	link
2017-02	Phase and structure control of metal compound and carbon hybrid nanofibers using thermodynamic redox reaction 남대현	view file
2018-04	Phase 2 study of the HSP-90 inhibitor AUY922 in previously treated and molecularly defined patients with advanced non-small cell lung cancer Felip, Enriqueta; Barlesi, Fabrice; Besse, Benjamin; Chu, Quincy; Gandhi, Leena; Kim, Sang-We; Carcereny, Enric; Sequist, Lecia V.; Brunsvig, Paal; Chouaid, Christos; Smit, Egbert F.; Groen, Harry J. M.; Kim, Dong-Wan; Park, Keunchil; Avsar, Emin; Szpakowski, Sebastian; Akimov, Mikhail; Garon, Edward B. Journal of Thoracic Oncology, Vol.13 No.4, pp.576-584	DOI
2012-12	Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas Oh, Do-Youn; Kim, Tae-Won; Park, Young Suk; Shin, Sang Joon; Shin, Seong Hoon; Song, Eun-Kee; Lee, Hyo Jin; Lee, Kewn-Wook; Bang, Yung-Jue Cancer, Vol.118 No.24, pp.6162-6170	DOI
2015-08	Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma Keam, Bhumsuk; Kim, Sung-Bae; Shin, Seong Hoon; Cho, Byoung Chul; Lee, Keun-Wook; Kim, Min Kyoung; Yun, Hwan-Jung; Lee, Se-Hoon; Yoon, Dok Hyun; Bang, Yung-Jue Cancer, Vol.121 No.15, pp.2612-2617	DOI
2020-02	Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette Cancer Science, Vol.111 No.2, pp.536-547	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2006	Phase 1 and 2 clinical studies of sustained-release praziquantel(SRP) for clonorchiasis 장병찬	link
2020-11	Phase 0/microdosing approaches: time for mainstream application in drug development? Burt, Tal; Young, Graeme; Lee, Wooin; Kusuhara, Hiroyuki; Langer, Oliver; Rowland, Malcolm; Sugiyama, Yuichi Nature Reviews Drug Discovery, Vol.19 No.11, pp.801-818	DOI
2006	Pharmdb: A database for the prediction of pharmacological targets based on an integrated drug-target network analysis 구민지	link
2015-11	PharmDB-K: Integrated bio-pharmacological network database for traditional Korean medicine Lee, Ji-Hyun; Park, Kyoung Mii; Han, Dong-Jin; Bang, Nam Young; Kim, Do-Hee; Na, Hyeongjin; Lim, Semi; Kim, Tae Bum; Kim, Dae Gyu; Kim, Hyun-Jung; Chung, Yeonseok; Sung, Sang Hyun; Surh, Young-Joon; Kim, Sunghoon; Han, Byung Woo PLoS ONE, Vol.10 No.11, p. e0142624	DOI
2013-08	Pharmacological mechanism underlying anti-inflammatory, anti-nociceptive and neuroprotective activities of anomalin and capillarisin 살만	view file
2015-07	Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through the inhibition of pro-inflammatory enzymes and cytokines Khan, Salman; Shehzad, Omer; Cheng, Mao-Sheng; Li, Rui-Juan; Kim, Yeong Shik Journal of Inflammation, 12(1):47	view file DOI
2021-03	Pharmacological interventions for pulmonary involvement in rheumatic diseases Kang, Eun Ha; Song, Yeong Wook Pharmaceuticals, Vol.14 No.3, p. 251	DOI
2020-12	Pharmacological inhibition of Kv3 on oxidative stress-induced cataract progression Song, Min Seok; Sim, Hun Ju; Park, Sangwan; Seo, Kangmoon; Lee, So Yeong Biochemical and Biophysical Research Communications, Vol.533 No.4, pp.1255-1261	DOI
2006-11	Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation Chu, K.; Lee, S. T.; Sinn, D. I.; Ko, S. Y.; Kim, E. H.; Kim, J. M.; Kim, S. J.; Park, D. K.; Jung, K. H.; Song, E. C.; Lee, S. K.; Kim, M.; Roh, J. K. Stroke. 2007 Jan;38(1):177-82. Epub 2006 Nov 22.	view file link
2007	Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage Sinn, Dong-In; Chu, Kon; Lee, Soon-Tae; Song, Eun-Cheol; Jung, Keun-Hwa; Kim, Eun-Hee; Park, Dong-Kyu; Kang, Kyung-Mook; Kim, Manho; Roh, Jae-Kyu Brain Res. 1135, 167-176	link
2007-01	Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage Sinn, D. I.; Chu, K.; Lee, S. T.; Song, E. C.; Jung, K. H.; Kim, E. H.; Park, D. K.; Kang, K. M.; Kim, M.; Roh, J. K. Brain Res. 2007 Mar 2;1135(1):167-76. Epub 2006 Dec 15.	link
2008-01	Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations Myrand, S. P.; Sekiguchi, K.; Man, M. Z.; Lin, X.; Tzeng, R. Y.; Teng, C. H.; Hee, B.; Garrett, M.; Kikkawa, H.; Lin, C. Y.; Eddy, S. M.; Dostalik, J.; Mount, J.; Azuma, J.; Fujio, Y.; Jang, I. J.; Shin, S. G.; Bleavins, M. R.; Williams, J. A.; Paulauskis, J. D.; Wilner, K. D. Clin Pharmacol Ther. 2008 Sep;84(3):347-61. Epub 2008 Mar 19.	link
2008-01	Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations Myrand, S P; Sekiguchi, K; Man, M Z; Lin, X; Tzeng, R-Y; Teng, C-H; Hee, B; Garrett, M; Kikkawa, H; Lin, C-Y; Eddy, S M; Dostalik, J; Mount, J; Azuma, J; Fujio, Y; Jang, I-J; Shin, S-G; Bleavins, M R; Williams, J A; Paulauskis, J D; Wilner, K D Clin Pharmacol Ther. 84(3), 347-361	link

1 4635 4636 4637 4638 4639 4640 4641 7348